Abundant expression of Kallikrein 1 gene in human keratinocytes was mediated by GATA3

Gene

Volumn 436, Issue 1-2, 2009, Pages 121-127

  Son, Do Ngoc ^a   Li, LiHua ^a   Katsuyama, Hironobu ^b   Komatsu, Nahoko ^a   Saito, Masayuki ^a   Tanii, Hideji ^a   Saijoh, Kiyofumi ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

GATA3; Human keratinocyte; Kallikrein 1 gene; Transcriptional regulation

Indexed keywords

ANTIBODY; KALLIKREIN; KALLIKREIN 1; LUCIFERASE; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR GATA 3 ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA FOOTPRINTING; ENZYME ASSAY; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; REGULATORY MECHANISM;

ANALYSIS OF VARIANCE; ANIMALS; BINDING SITES; CELL LINE; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; LUCIFERASES, FIREFLY; MICE; MUTATION; NIH 3T3 CELLS; OLIGONUCLEOTIDES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE KALLIKREINS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 62549125370     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2009.02.002     Document Type: Article

References (22)

1. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44 (1992) 1-80
2. Brattsand M., and Egelrud T. Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem. 274 (1999) 30033-30040
3. Chapman S.J., and Walsh A. Desmosomes, corneosomes and desquamation. An ultrastructural study of adult pig epidermis. Arch. Dermatol. Res. 282 (1990) 304-310
4. Diamandis E.P., Yousef G.M., Luo L.Y., Magklara A., and Obiezu C.V. The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab. 11 (2000) 54-60
5. Ekholm E., and Egelrud T. Expression of stratum corneum chymotryptic enzyme in relation to other markers of epidermal differentiation in a skin explant model. Exp. Dermatol. 9 (2000) 65-70
6. Ekholm I.E., Brattsand M., and Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process?. J. Invest. Dermatol. 114 (2000) 56-63
7. Fujii S., et al. Differential expression of neuroendocrine-specific protein in form-deprived chick eyes. Invest. Ophthalmol. 41 (2000) 1533-1541
8. Hansson L., Stromqvist M., Backman A., Wallbrandt P., Carlstein A., and Egelrud T. Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem. 269 (1994) 19420-19426
9. Kingston R.E. Prepatation of nuclear and cytoplasmic extracts from mammalian cells. In: Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K. (Eds). Current Protocols in Molecular Biology (1993), John Wiley and Sons Inc., New York unit 12
10. Komatsu N., et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J. Invest. Dermatol. 118 (2002) 436-443
11. Komatsu N., et al. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. J. Invest. Dermatol. 125 (2005) 1182-1189
12. Komatsu N., et al. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br. J. Dermatol. 153 (2005) 274-281
13. Kurek D., Garinis G.A., van Doorninck J.H., van der Wees J., and Grosveld F.G. Transcriptome and phenotypic analysis reveals Gata3-dependent signalling pathways in murine hair follicles. Development 134 (2007) 261-272
14. Lundstrom A., and Egelrud T. Evidence that cell shedding from plantar stratum corneum in vitro involves endogenous proteolysis of the desmosomal protein desmoglein I. J. Invest. Dermatol. 94 (1990) 216-220
15. Lundwall A., et al. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biol. Chem. 387 (2006) 637-641
16. Murray S.R., Chao J., Lin F.K., and Chao L. Kallikrein multigene families and the regulation of their expression. J. Cardiovasc. Pharmacol. 15 (1990) S7-S16
17. Oka R., Sasagawa T., Ninomiya I., Miwa K., Tanii H., and Saijoh K. Reduction in the local expression of complement component 6 (C6) and 7 (C7) mRNA in oesophageal carcinoma. Eur. J. Cancer 37 (2001) 1158-1165
18. Simon M., et al. Refined characterization of coreodesmosin proteolysis during tereminal differentiation of human epidermis and its relationship to desquamation. J. Biol. Chem. 276 (2001) 20292-20299
19. Smith V.M., Lee P.P., Szychowski S., and Winoto A. GATA-3 dominant negative mutant. Functional redundancy of the T cell receptor alpha and beta enhancers. J. Biol. Chem. 270 (1995) 1515-1520
20. Suzuki Y., et al. The role of two endogenous proteases of the stratum corneum in degradation of desmoglein-1 and their reduced activity in the skin of ichthyotic patients. Br. J. Dermatol. 134 (1996) 460-464
21. Vicanová J., Mommaas A.M., Mulder A.A., Koerten H.K., and Ponec M. Impaired desquamation in the in vitro reconstructed human epidermis. Cell Tissue Res. 286 (1996) 115-122
22. Yousef G.M., and Diamandis E.P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22 (2001) 184-204